Racecadotril

Specifications

81110-73-8CAS Number

688-010-7EC Number

benzyl 2-[[2-(acetylsulfanylmethyl)-3-phenylpropanoyl]amino]acetateIUPAC Name

C21H23NO4SChemical Formula

385.5 g/molMolecular Weight

Racecadotril; 81110-73-8; Acetorphan; Hidrasec; Tiorfan; Tiorfix; racecadotrilo; NSC-759828; 76K53XP4TO; benzyl 2-[[2-(acetylsulfanylmethyl)-3-phenylpropanoyl]amino]acetate; Glycine, N-(2-((acetylthio)methyl)-1-oxo-3-phenylpropyl)-, phenylmethyl ester, (+-)-; DTXSID8045513; racecadotrilum; benzyl 2-((2-(acetylsulfanylmethyl)-3-phenylpropanoyl)amino)acetate; RefChem:178501; A07XA04; DTXCID00209955; N-(3-acetylmercapto-2-benzylpropanoyl)glycine benzyl ester; benzyl 2-(2-((acetylsulfanyl)methyl)-3-phenylpropanamido)acetate; Benzyl 2-(3-(acetylthio)-2-benzylpropanamido)acetate; Racecadotril [INN]; MFCD00865520; benzyl (3-(acetylthio)-2-benzylpropanoyl)glycinate; (+/-)-ACETORPHAN; Racecadotril (INN); Glycine, N-[2-[(acetylthio)methyl]-1-oxo-3-phenylpropyl]-,phenylmethyl ester [CAS]; S049; Sinorphan; SMR000449320; SR-01000759384; Racecadotril [INN:BAN]; Benzyl 2-[3-(Acetylthio)-2-benzylpropanamido]acetate; UNII-76K53XP4TO; Racecadotril CRS; 2-[[2-[(acetylthio)methyl]-1-oxo-3-phenylpropyl]amino]acetic acid (phenylmethyl) ester; 2-{[2-[(acetylthio)methyl]-1-oxo-3-phenylpropyl]amino}acetic acid (phenylmethyl) ester; Racecadotril; Benzyl [[(2RS)-2-[(acetylsulfanyl)methyl]-3-phenylpropanoyl]amino]acetate; Hidrasec (TN); Prestwick_926; Tiorfan (TN); (+/-)-Racecadotril; CPD000449320; Racecadotril (Standard); Prestwick0_000626; Prestwick1_000626; Prestwick2_000626; Prestwick3_000626; Racecadotril (Acetorphan); RACECADOTRIL [MI]; Racecadotril Impurity 39; ACETORPHAN [VANDF]; (+-)-N-(2-((Acetylthio)methyl)-1-oxo-3-phenylpropyl)glycine phenylmethyl ester; Glycine, N-(2-((acetylthio)methyl)-1-oxo-3-phenylpropyl)-, phenylmethyl ester; BSPBio_000592; RACECADOTRIL [MART.]; MLS000758279; MLS001423958; MLS006010032; RACECADOTRIL [WHO-DD]; SCHEMBL373243; SPBio_002811; BPBio1_000652; orb1309511; CHEMBL2103772; CHEBI:91508; GTPL11654; Racecadotril - Bio-X trade mark; Racecadotril, >=98% (HPLC); Glycine, N-[(2R)-2-[(acetylthio)methyl]-1-oxo-3-phenylpropyl]-, phenylmethyl ester; ODUOJXZPIYUATO-UHFFFAOYSA-N; GLXC-07941; HMS1569N14; HMS2051K05; HMS2090L07; HMS2096N14; HMS2232F17; HMS3370B22; HMS3393K05; HMS3656C10; HMS3713N14; HMS3744I15; HMS3884F04; HMS5081A15; Pharmakon1600-01502331; RACECADOTRIL [EP MONOGRAPH]; WZB81511; BDBM50247884; benzyl 2-[[2-(acetylsulfanylmethyl)-3-phenyl-propanoyl]amino]acetate; EBC-11207; HY-17399R; NSC759828; s2503; AKOS015894948; N-[2-[(Acetylthio)methyl]-1-oxo-3-phenylpropyl]glycine phenylmethyl ester; AB07493; AC-1133; CCG-100764; CCG-213824; CS-1127; DB11696; FR27638; HS-0029; NC00014; NSC 759828; (+-)-N-(alpha-(Mercaptomethyl)hydrocinnamoyl)glycine, benzyl ester, acetate (ester); Racecadotril for peak identification CRS; NCGC00179511-01; NCGC00179511-04; NCGC00179511-14; BR164305; HY-17399; SY054810; DB-015177; NS00009279; R0103; SW197043-4; D08464; F093432; Q416677; SR-01000759384-4; SR-01000759384-5; Benzyl N-[3-(Acetylthio)-2-benzylpropionyl]glycinate; BRD-A08187463-001-03-8; BRD-A08187463-001-11-1; BRD-A08187463-001-12-9; benzyl (3-(acetylthio)-2-benzylpropanoyl)glycylglycinate; N-[3-Acetylthio-2-benzylpropanoyl]glycine benzyl ester; N-[3-(Acetylthio)-2-benzylpropionyl]glycine Benzyl Ester; Racecadotril, European Pharmacopoeia (EP) Reference Standard; Benzyl N-{2-[(acetylsulfanyl)methyl]-3-phenylpropanoyl}glycinate; N-((R,S)-3-ACETYLTHIO-2-BENZYLPROPANOYL)GLYCINE BENZYL ESTER; (2-ACETYLSULFANYLMETHYL-3-PHENYL-PROPIONYLAMINO)-ACETIC ACID BENZYL ESTER; Racecadotril for peak identification, European Pharmacopoeia (EP) Reference Standard; (+/-)-N-(.ALPHA.-(MERCAPTOMETHYL)HYDROCINNAMOYL)GLYCINE, BENZYL ESTER, ACETATE (ESTER)Synonyms